Escherichia coli O157:H7 gastroenteritis and the hemolytic uremic syndrome: an emerging infectious disease.
about
Future perspectives, applications and challenges of genomic epidemiology studies for food-borne pathogens: A case study of Enterohemorrhagic Escherichia coli (EHEC) of the O157:H7 serotypeAdvances in pathogenesis and therapy of hemolytic uremic syndrome caused by Shiga toxin-2Isolation and characterization of a new T-even bacteriophage, CEV1, and determination of its potential to reduce Escherichia coli O157:H7 levels in sheepUse of in vivo-induced antigen technology for identification of Escherichia coli O157:H7 proteins expressed during human infection.Outbreak of Shiga toxin-producing Escherichia coli O111:H8 infections among attendees of a high school cheerleading camp.Hemolytic uremic syndrome incidence in New York.Sporadic bloody diarrhoea-associated thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome: an adult and paediatric comparison.Seasonal association of thrombotic thrombocytopenic purpura.Progress towards recombinant anti-infective antibodies.Phase 1 safety and pharmacokinetic study of chimeric murine-human monoclonal antibody c alpha Stx2 administered intravenously to healthy adult volunteers.Persistence of Escherichia coli O157:H7 and its mutants in soils.A descriptive review of selected nonviral enteric illnesses reported in children in Quebec between 1999 and 2006.Identification of a novel prophage regulator in Escherichia coli controlling the expression of type III secretion.Gastrointestinal tract location of Escherichia coli O157:H7 in ruminantsRapid detection of Shiga toxin-producing bacteria in feces by multiplex PCR with molecular beacons on the smart cyclerCarriage of stx2a differentiates clinical and bovine-biased strains of Escherichia coli O157.Multilocus sequence typing reveals a lack of diversity among Escherichia coli O157:H7 isolates that are distinct by pulsed-field gel electrophoresis.Multilocus variable-number tandem repeat analysis distinguishes outbreak and sporadic Escherichia coli O157:H7 isolatesA prospective case-control and molecular epidemiological study of human cases of Shiga toxin-producing Escherichia coli in New Zealand.Genome signatures of Escherichia coli O157:H7 isolates from the bovine host reservoir.Comparison of a PCR-restriction fragment length polymorphism (PCR-RFLP) assay to pulsed-field gel electrophoresis to determine the effect of repeated subculture and prolonged storage on RFLP patterns of Shiga toxin-producing Escherichia coli O157:H7Detection of shiga toxins by lateral flow assayGenomic anatomy of Escherichia coli O157:H7 outbreaks.Microarray analysis of Escherichia coli O157:H7Development of a Flow Cytometry-Based Method for Rapid Detection of Escherichia coli and Shigella Spp. Using an Oligonucleotide Probe.Shiga toxins, and the genes encoding them, in fecal samples from native Idaho ungulatesEvaluation of performance and potential clinical impact of ProSpecT Shiga toxin Escherichia coli microplate assay for detection of Shiga Toxin-producing E. coli in stool samples.Genome Sequence of Escherichia coli O157:H7 Strain 2886-75, Associated with the First Reported Case of Human Infection in the United StatesRole of virulence factors on host inflammatory response induced by diarrheagenic Escherichia coli pathotypes.Protection against Escherichia coli O157:H7 challenge by immunization of mice with purified Tir proteins.Escherichia coli O157:H7 colonization in cattle following systemic and mucosal immunization with purified H7 flagellin.The role of Tir, EspA, and NleB in the colonization of cattle by Shiga toxin producing Escherichia coli O26:H11.Amoeba-related health risk in drinking water systems: could monitoring of amoebae be a complementary approach to current quality control strategies?Lymphoid follicle-dense mucosa at the terminal rectum is the principal site of colonization of enterohemorrhagic Escherichia coli O157:H7 in the bovine host.Nonpathogenic Escherichia coli can contribute to the production of Shiga toxin.Inhibition of development of Shiga toxin-converting bacteriophages by either treatment with citrate or amino acid starvation.Hemolytic uremic syndrome caused by E. coli O157 infection.Role of Shiga toxin versus H7 flagellin in enterohaemorrhagic Escherichia coli signalling of human colon epithelium in vivo.Evaluation of Rectoanal Mucosal Swab Sampling for Molecular Detection of Enterohemorrhagic Escherichia coli in Beef Cattle.Differential virulence of clinical and bovine-biased enterohemorrhagic Escherichia coli O157:H7 genotypes in piglet and Dutch belted rabbit models.
P2860
Q26825123-335E7304-8493-4C08-BCBD-ACC10B0B282CQ26863602-73EF2F40-CE2E-4249-B944-CDF554101516Q28390402-F4D1F826-29F2-461E-9777-1BD1B736505BQ33214290-CF1A139D-1998-4CAB-B539-20CB850D1E4BQ33358383-6CB43BEF-FED6-41C1-8632-81235B991634Q33361312-5B0B2C63-CB79-4C20-A1B7-BDDEDED25B52Q33379319-52688461-3CBE-4F23-8234-BAC17C3520B1Q33399175-E2845958-7EEF-413A-B759-DE9B15A825C8Q33568256-DCA8A98A-F449-49EE-9DAC-D60441A6A6DCQ33770199-03614DAA-AA77-4000-B1E5-37302129F393Q33986145-A8D2929E-DA25-4CB7-B4C9-75CCC98B67B2Q34028362-B43E8920-6983-4DDB-BA78-061079CEDEC4Q34082078-D8B8D210-E470-44F2-A163-45ADBBFB523DQ34114291-1B199ACA-3996-4C5E-B6A8-0C739D226607Q34452904-8797FDA1-5B19-4448-AD8D-1A34E441EC86Q34512492-092597AC-184B-447B-B47E-116087153FECQ34750677-5905062A-1ADD-4900-BC4C-936A9A09F2C9Q34950346-E0AF317C-2CBA-49FC-B892-59E3C078915AQ35002251-B4A03D4A-CF2C-4F3B-A174-EEBF1793D3FDQ35077276-4A719151-6BB2-47C7-9D65-6C48D3F9883FQ35220829-44DD91D5-94AB-4986-AB72-631B8832E6AEQ35564037-D267E438-E558-4862-A7D4-15BCB133EAADQ35647800-B67D5165-0AB0-414B-8999-B6BA005663FAQ35777662-1319FE8B-785A-4712-ADDC-921D85F5C642Q35935359-C2DB2CC4-85B5-41BB-A3ED-E727C79BD035Q37075626-80D3E07C-9666-41D1-AD07-84D282FBD016Q37420029-682E0EF9-D6FC-476E-8575-88167E1F5303Q37458365-B380B4E3-F9C7-4E42-94DC-FC525AFE1921Q38522801-D9736165-CC98-4CAE-B0D2-62C7001ACDF9Q38998590-FD411D63-2E00-4897-952B-413CDDD0F16FQ39023163-FB66CA26-3DC3-4721-85EA-C1830866E53BQ39648124-50598406-EAC4-4910-A890-14A515F623DFQ39673011-4F96D0A3-6A92-4401-9B0D-787BF7C4F6CAQ39730268-E72693ED-D353-42F2-9659-2970F7FDB06FQ39755249-70333963-C821-422E-8443-1B37E64FC634Q40136415-E6E17D2F-0470-4902-8442-C02BE6366F8BQ40274134-2B1C1BD1-5958-4AB6-816A-5D5D08A89225Q40293264-12E87BF9-2476-4199-9009-57F863044635Q40293763-112D7CFE-2E0E-4A9F-9F67-A74E3F784019Q40312938-045AD84D-BA05-4D09-A42F-76D3F099D1A9
P2860
Escherichia coli O157:H7 gastroenteritis and the hemolytic uremic syndrome: an emerging infectious disease.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Escherichia coli O157:H7 gastr ...... n emerging infectious disease.
@ast
Escherichia coli O157:H7 gastr ...... n emerging infectious disease.
@en
Escherichia coli O157:H7 gastr ...... n emerging infectious disease.
@nl
type
label
Escherichia coli O157:H7 gastr ...... n emerging infectious disease.
@ast
Escherichia coli O157:H7 gastr ...... n emerging infectious disease.
@en
Escherichia coli O157:H7 gastr ...... n emerging infectious disease.
@nl
prefLabel
Escherichia coli O157:H7 gastr ...... n emerging infectious disease.
@ast
Escherichia coli O157:H7 gastr ...... n emerging infectious disease.
@en
Escherichia coli O157:H7 gastr ...... n emerging infectious disease.
@nl
P2093
P1476
Escherichia coli O157:H7 gastr ...... n emerging infectious disease.
@en
P2093
P304
P356
10.1146/ANNUREV.MED.50.1.355
P577
1999-01-01T00:00:00Z